Atisnolerbart Biosimilar - Research Grade

Human

BETVIA

5mg/ml

Human IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH2774

Blue ice

Bet v 1a (BETVIA) is the major birch-pollen allergen and a principal antigen in allergy and immunotherapy research. This recombinant anti-BETVIA monoclonal is an unconjugated, non-therapeutic analog of atisnolerbart, supplied for research use only (RUO). It is manufactured to in vivo standards, carries low endotoxin, and is offered in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. Use it in functional assays, allergen-binding and IgE-blocking studies, reproducible controls, and in vivo models of allergic sensitisation, relying on consistent lot-to-lot performance for extended, heavy-usage allergy research.

Major pollen allergen Bet v 1-A

Detects human BETVIA

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

4 weeks